Clinical Trial

JARVISDHL Screening Tools

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 23, 2022 (before its estimated June 30, 2024 completion). Its status may not reflect the trial's current state.
Summary
The main purpose of this study is to pioneer an easy risk stratification tools, which is developed using novel artificial intelligence (AI) algorithms, that will be able to detect common and fatal heart diseases easily simply through a picture of the back of the eye, the retina. The retinal images will be analysed using a computer application with the risk stratification tool to predict health outcome of individual. The study also aims to correlate between clinical characteristics, lifestyle (eg. exercise, sleep, erectile dysfunction) and diet to retinal and coronary vasculature and clinical outcomes.
Trial Details
NCT Number NCT05626517
Lead Sponsor National Heart Centre Singapore
Collaborators: Singapore Eye Research Institute
Conditions Coronary Artery Disease
Enrollment 2,000 participants
Start Date 2023-01-30
Primary Completion 2024-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2022-11-23